Lansforsakringar Fondforvaltning’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$107M Buy
830,507
+25,680
+3% +$3.01M 0.48% 36
2026
Q1
$96.8M Sell
804,827
-63,102
-7% -$7.29M 0.51% 31
2025
Q4
$91.4M Buy
867,929
+11,186
+1% +$1.05M 0.45% 33
2025
Q3
$71.9M Buy
856,743
+19,036
+2% +$1.57M 0.37% 43
2025
Q2
$66.3M Sell
837,707
-47,526
-5% -$3.78M 0.38% 51
2025
Q1
$79.5M Sell
885,233
-28,167
-3% -$2.63M 0.49% 34
2024
Q4
$90.9M Buy
+913,400
New +$94.2M 0.51% 32

Other funds holding MRK

Lansforsakringar Fondforvaltning's MRK Position: Q2 2026 in Review

Lansforsakringar Fondforvaltning increased its Merck (MRK) stake by 3.2% in Q2 2026, buying an estimated $3.01M and bringing the position to 830,507 shares worth $107M. The position accounts for 0.48% of the portfolio, ranked #36.

Lansforsakringar Fondforvaltning first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Lansforsakringar Fondforvaltning held 830,507 shares of Merck worth $107M as of Q2 2026.
  • Lansforsakringar Fondforvaltning bought 25,680 Merck shares in Q2 2026, an estimated $3.01M.
  • Merck made up 0.48% of Lansforsakringar Fondforvaltning's portfolio in Q2 2026, its #36 holding.
  • Lansforsakringar Fondforvaltning first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q2 2026, filed 13 Aug 2026.